The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.80
Bid: 57.40
Ask: 58.00
Change: 0.50 (0.87%)
Spread: 0.60 (1.045%)
Open: 57.00
High: 57.80
Low: 57.00
Prev. Close: 57.20
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Jul 2010 07:00

RNS Number : 4913P
Accsys Technologies PLC
19 July 2010
 



 

 

 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

19 July 2010

ACCSYS TECHNOLOGIES PLC

("Accsys" or "the Company")

Interim Management Statement

• Benefits from process improvements start to be seen;

• Accoya® wood revenue record of €3.2m in the last quarter, a 46% increase compared to same quarter last year;

• Staff costs reduced by 23% in the quarter, equivalent to annualised saving of €2.8m; and

• Introduction of Accoya® wood at the American Institute of Architects exhibition in USA.

In the first quarter of the financial year, Accsys has started to see the benefits of the process improvements implemented over the course of the previous 12 months. In the three months to 30 June 2010, the Company achieved record Accoya® wood sales and record production volumes at the production plant in Arnhem. 

Accoya® wood revenue of €3.2m for the quarter ended 30 June 2010 is a 46% increase compared to the same quarter of last year. Production volumes have increased by 76% from 2,161m3 to 3,805m3 for the same period, reflecting forward sales.

The improving performance of the Arnhem plant continues to be supported by the growing international network of distribution, supply and agency agreements with two agreements being signed since 31 March 2010, making a total of 19. In addition, Accsys continues to have a working relationship with a further 14 distributors and agents in key markets which have enabled the Company to sell Accoya® wood in 17 countries.

While Accsys continues to focus on decreasing costs and generating efficiencies, the benefits of last year's improvements and headcount reduction have had a positive impact on operating costs. Staff costs for the quarter ended 30 June 2010 were 23% less than the same quarter last year, which is equivalent to an annualised saving of €2.8m.

In June 2010, the American Institute of Architects national exhibition in Miami, USA was the premier event to introduce Accoya® wood to American architects. The event combined product and brand exposure to the most significant architecture firms in the USA, resulting in a significant number of sales leads. Moreover, considerable media interest and coverage is expected over the next few weeks.

Accsys was also proud of the use of Accoya® wood in the Florida International University's Solar Decathlon competition entry, with the team's award-winning design utilising sustainable materials in the zero-energy house. 

The Company is extremely pleased with the outcome of negotiations that resulted in an amended Licence Agreement with Diamond Wood China Limited ('Diamond Wood') which we announced on 21 June 2010. The amended Licence Agreement now reflects Diamond Wood's new business plan, which has been re-modelled to reflect their proposed funding arrangements. The amended Licence Agreement includes, inter alia, revised licence fee and royalty terms, with benefits for both parties. 

On 30 June 2010, following Diamond Wood's AGM, Accsys announced that they were in advanced discussions with two independent parties who were interested in investing sufficient funds for the construction of the first Accoya® wood manufacturing facility in Nanjing, China. Diamond Wood had received an acceptable terms sheet from one of these parties and were continuing discussions with the other party. Since then, the Company has continued to work with Diamond Wood in anticipation of the fundraising being completed in the near future.

The core business strategy remains the licensing of the Company's transformational technologies and the business development team has continued positive discussions with a number of other companies with a view to forming commercial alliances.

Paul Clegg, CEO, commented: "I am pleased by the progress that has been made at our Arnhem plant with the record sales and production figures in the first quarter having been possible as a result of the improvements made last year. We continue to look forward to the completion of Diamond Wood's fundraising and continue to make progress in identifying other companies with whom we are having constructive discussions concerning potential agreements to use our technology."

Ends

 

 

Accsys Technologies PLC

Paul Clegg, Chief Executive Officer

Hans Pauli, Chief Financial Officer

+44 20 8150 8835

+31 26 366 1408

Matrix Corporate Capital LLP

 

Stephen Mischler

Anu Tayal

+44 20 3206 7000

 

Threadneedle Communications

 

 

Graham Herring

Josh Royston

graham.herring@threadneedlepr.co.uk

josh.royston@threadneedlepr.co.uk

+44 20 7653 9850

Citigate First Financial B.V.

Wouter van de Putte 

Menno Delken

+ 31 20 575 4080

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGMNFVMGGZM
Date   Source Headline
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.